Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink
Kayla E. Hanson et al. Are COVID-19vaccines associated with Guillain-Barré syndrome (GBS)? In this cohort study of surveillance data from the Vaccine Safety Datalink that included 15.1 million doses of COVID-19 vaccines, the unadjusted incidence rate of confirmed GBS in the 1 to 21 days after receiving the Ad.26.COV2.S (Janssen) vaccine was 32.4 per 100 […]
On the Use of the Pfizer and the Moderna COVID-19 mRNA Vaccines in Children and Adolescents
Michael Palmer, Sucharit Bhakdi, Wolfgang Wodarg This document provides a comprehensive risk-benefit analysis of the use of the Pfizer andModerna COVID-19 vaccines in children and adolescents, and it makes the case that thevaccines are neither needed nor safe and have not been proven to be efficacious, particularly when considering the Omicron variant of SARS-CoV-2, which […]
